INTS stock

Intensity Therapeutics, Inc. Common stock (INTS) financials · $7.7M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Intensity Therapeutics, Inc. Common stock (INTS) $7.7M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$12.0M-$16.6M
Net Income-$11.6M-$16.3M
EPS (Diluted)-$8.56-$1.17
Cached annual balance sheet
LineFY2025FY2024
Total Assets$14.1M$4.78M
Current Assets$12.7M$3.36M
Cash & Equivalents$11.9M$2.59M
Total Liabilities$2.23M$1.86M
Current Liabilities$2.15M$1.75M
Shareholders' Equity$11.9M$2.92M
Retained Earnings-$78.4M-$66.8M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$9.23M-$15.2M
Investing Cash FlowN/A$6.35M
Financing Cash Flow$18.6M$2.90M
Net Change in Cash$9.33M-$5.97M
These statements as JSON? API free 100/day

FAQ

What is INTS P/E and revenue?

Intensity Therapeutics, Inc. Common stock (INTS) $7.7M cap.

What is INTS revenue?

INTS income-statement cache has no revenue figure yet.

Is INTS profitable?

Intensity Therapeutics, Inc. Common stock last cached net income is -$11.6M (FY2025).

What are INTS total assets?

Intensity Therapeutics, Inc. Common stock last cached total assets are $14.1M (FY2025).

What is INTS free cash flow?

No cached cash-flow row for INTS yet.

Not investment advice. Cached statements, not a live tape.